In February of 2000 the Research Group on Biomedical Informatics participated in the genomic sequencing of the Drosophila melanogaster by making available the “gff2ps” application, a tool used for genomic analysis.
This application was originally developed by the RGBI for use in its own research. The application became of public knowledge through the web and Celera Genomics learned about its existence. IMIM’s collaboration in the project has been purely scientific since IMIM is a public organization. This work was published in Science in March.
In October of 2000 the RGBI participated in the sequencing of the Human Genome, with the "gff2ps" application, a tool used in genomic analysis developed by RGBI and previously used by Celera Genomics in the sequencing of the Drosophila melanogaster. For the Human Genome Project the RGBI adapted the program due to the dimensions of the human genome. This work was published in Science in February of 2000.
Affiliation to the Universitat Pompeu Fabra (UPF) as a University Institute Since July of 2000 IMIM has been affiliated to the University Pompeu Fabra (UPF) by a decree of the Generalitat de Catalunya (Catalan Government). In conjunction with IMIM's status as a University Institute, IMIM’s presence today would be hard to fathom without its direct link to the University Pompeu Fabra and specifically to the newly created Health and Life Sciences studies.
IMIM handed over the space to UPF thus these studies were launched in IMIM's premises. The result has been an academic unfolding leading to the creation of the Department of Experimental and Health Sciences (Dept. CEXS) at the UPF with a highly qualified new faculty that is building new research groups in the same setting. Thus not only are general and technico-scientific services shared but also the scientific environment is fostered because new faculty are added every year consisting of university level teachers whose expertise encompass the fields of Intracellular Signalization, Genic Regulation, Genetics and Genomics, among others.
IMIM participates very actively in UPF's academic programs such as the Doctorate Program in Health and Life Sciences, a program to train researchers that stands out for its multidisciplinary character. The program offers three possible lines of specialization in the fields of basic research, clinical research and research in Public Health, respectively. Elaboration of the Code of Good Scientific Practice In 2000, scientists from both institutions (IMIM and the Dept. CEXS of the UPF) provided themselves with a Code of Good Scientific Practice.
This is a relevant initiative consisting of rules adopted freely and voluntarily by scientists not only to preserve the integrity of the research they conduct but also to guarantee its best quality and excellence. Joint agreement for the beginning of the PRBB
IMIM is one of the main institutions driving the creation and start up of the Biomedical Research Parc of Barcelona (PRBB), a scientific and innovative project aiming at ranking Barcelona as one of the main biomedical research capitals in Europe. To make the project possible an agreement was signed on April 11 of 2000 between the Barcelona City Council, the Departments of Universites, Research and Information Society (DURSI) and the Department of Health and Social Security of the Generalitat of Catalonia, the Universitat Pompeu Fabra and IMAS.
On September 23, 2000 the minister of Science and Technology, Anna Birules and Barcelona's Mayor, Joan Clos, presided the ceremony to open the construction site. The PRBB, a university scientific parc, has a strategic objective consisting of bringing together and optimizing human, technico-scientific and logistic resources to achieve excellent research, innovative and outstanding teaching and the highest quality health care.
The following institutions create the Principal Scientific Core: Institut Municipal d'Investigació Mèdica (IMIM) Department of Experimental and Health Sciences (Dep. CEXS) of the UPF, and the Center for Genomic Regulation (CRG). El PRBB will concentrate their scientific research in the following fields: Cancer and Celullar Differentiation, Genomics and Genic Regulation, Epidemiology and Public Health, Physiopathology and Therapeutic Developments, Bioinformatics and Biomedical Informatics. Creation of the PRBB Foundation
The Fundació PRBB was created on June 22, 2002, by the foundations of the University Pompeu Fabra, the Municipal Institute of Medical Research and the Center for Genomic Regulation. The Honorable Minister Andreu Mas-Colell, who was the President of the Center for Genomic Regulation Foundation, presided over the PRBB Foundation. Professor Rosa Virós, who was the Rector of the University Pompeu Fabra and Mr. Jose I. Cuervo, Deputy Mayor of Barcelona and the President of the Municipal Institute of Medical Research Foundation, were also distinguished members of the Board of the Fundació PRBB. The Director is Dr. Jordi Camí.
The move to the new facilities of the Barcelona Biomedical Research Park (PRBB) began in July 2006. The first group to relocate was the Research Unit on Biomedical Informatics (GRIB), which moved into the fourth floor of the building. This part of the move was highly complicated, especially where the computer servers were concerned, since it was done without any downtime.
In the middle of October 2006, all the administration and management groups were moved, as well as the research groups without a laboratory, i.e. the Epidemiology research groups. This second phase was completed at the end of October with the relocation of these groups to the first floor of the new centre.
The last phase of the move, involving the groups that did have laboratories, began in January 2007 and ended in February. A delicate aspect of this phase was the -80 º freezers, as they were moved with samples inside, and the samples in the -20 º freezers, which were relocated using carbon dioxide snow and special containers in order to prevent any damage.
Thanks to the coordination efforts of the General Services teams, the coordinators from the Research Units and the specialised companies that participated, the move was a complete success.